Journal
JOURNAL OF NEUROINFLAMMATION
Volume 18, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12974-021-02325-6
Keywords
Neurodegenerative diseases; PI3K; AKT; Cell signaling; Innate immune system; Glia
Categories
Funding
- Australia Government
- National Health and Medical Research Council of Australia (NHMRC)
- Monash University Central Clinical School
- Alfred Medical Research and Education Precinct (AMREP)
- Capstone Editing
Ask authors/readers for more resources
Microglia play crucial roles in innate immunity within the mammalian central nervous system, but prolonged activation can lead to chronic neuroinflammation and neurodegenerative disease. Abnormalities in the PI3K-AKT signaling pathway in microglia may contribute to altered microglial activity and exacerbated neuroimmune responses. Modulation of microglial PI3K-AKT signaling shows promise as a therapeutic approach for various neuroinflammatory conditions.
Microglia are integral mediators of innate immunity within the mammalian central nervous system. Typical microglial responses are transient, intending to restore homeostasis by orchestrating the removal of pathogens and debris and the regeneration of damaged neurons. However, prolonged and persistent microglial activation can drive chronic neuroinflammation and is associated with neurodegenerative disease. Recent evidence has revealed that abnormalities in microglial signaling pathways involving phosphatidylinositol 3-kinase (PI3K) and protein kinase B (AKT) may contribute to altered microglial activity and exacerbated neuroimmune responses. In this scoping review, the known and suspected roles of PI3K-AKT signaling in microglia, both during health and pathological states, will be examined, and the key microglial receptors that induce PI3K-AKT signaling in microglia will be described. Since aberrant signaling is correlated with neurodegenerative disease onset, the relationship between maladapted PI3K-AKT signaling and the development of neurodegenerative disease will also be explored. Finally, studies in which microglial PI3K-AKT signaling has been modulated will be highlighted, as this may prove to be a promising therapeutic approach for the future treatment of a range of neuroinflammatory conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available